Skip to content
zameds

Idarubicin (Zavedos Rtu, Zavedos)

Idarubicin

Pfizer Laboratories (Pty) Ltd

S4

Registration

Applicant
Pfizer Laboratories (Pty) Ltd
Registrations
5
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Zavedos rtu 5

EACH 5,0 ml SOLUTION CONTAINS IDARUBICIN HYDROCHLORIDE 5,0 mg

533021133/26/0211RegisteredS4None
Zavedos rtu 10

EACH 10,0 ml SOLUTION CONTAINS IDARUBICIN HYDROCHLORIDE 10,0 mg

1033021233/26/0212RegisteredS4None
Zavedos rtu 20

EACH 20,0 ml SOLUTION CONTAINS IDARUBICIN HYDROCHLORIDE 20,0 mg

2033021333/26/0213RegisteredS4None
Zavedos 5 MG

EACH VIAL CONTAINS IDARUBICIN HYDROCHLORIDE 5 mg

5 mgY0016Y/26/16RegisteredS4None
Zavedos 10 MG

EACH VIAL CONTAINS IDARUBICIN HYDROCHLORIDE 10 mg

10 mgY0017Y/26/17RegisteredS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Idarubicin hydrochloride

  • S4: Idarubicin

    Consolidated Schedules 06 July 2026, line 6712

Pharmacological class: Cytostatic agents (class 26)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C26H27NO9497.50 g/mol

(7S,9S)-9-Acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione

Drag to rotate. Structure from PubChem CID 42890.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles